` Comparison: RHO5, NOVN - Alpha Spread

RHO5
vs
NOVN

Over the past 12 months, RHO5 has underperformed NOVN, delivering a return of 0% compared to the NOVN's +25% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
RHO5
NOVN
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

RHO5 Intrinsic Value
328.9 EUR
Undervaluation 25%
Intrinsic Value
Price
NOVN Intrinsic Value
115.31 CHF
Undervaluation 1%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Roche Holding AG
XBER:RHO5
245.95 EUR
Novartis AG
SIX:NOVN
113.6 CHF
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
RHO5, NOVN

RHO5
NOVN
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Roche Holding AG
Revenue
Novartis AG
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
RHO5, NOVN

RHO5
NOVN
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Roche Holding AG
XBER:RHO5
Novartis AG
SIX:NOVN
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

RHO5
73.9%
NOVN
76.1%
LTM 3Y Avg 5Y Avg 10Y Avg
Roche Holding AG
Novartis AG

Operating Margin

RHO5
33.8%
NOVN
33.1%
LTM 3Y Avg 5Y Avg 10Y Avg
Roche Holding AG
Novartis AG

Net Margin

RHO5
15.3%
NOVN
25.7%
LTM 3Y Avg 5Y Avg 10Y Avg
Roche Holding AG
Novartis AG

FCF Margin

RHO5
21.4%
NOVN
30.5%
LTM 3Y Avg 5Y Avg 10Y Avg
Roche Holding AG
Novartis AG

ROE

RHO5
32.7%
NOVN
32.8%
LTM 3Y Avg 5Y Avg 10Y Avg
Roche Holding AG
Novartis AG

ROA

RHO5
9.9%
NOVN
13.7%
LTM 3Y Avg 5Y Avg 10Y Avg
Roche Holding AG
Novartis AG

ROIC

RHO5
19.4%
NOVN
18.2%
LTM 3Y Avg 5Y Avg 10Y Avg
Roche Holding AG
Novartis AG

ROCE

RHO5
30.5%
NOVN
24.6%
LTM 3Y Avg 5Y Avg 10Y Avg
Roche Holding AG
Novartis AG

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
RHO5, NOVN

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
RHO5, NOVN

Loading
RHO5
NOVN
Difference
www.alphaspread.com

Performance By Year
RHO5, NOVN

Loading
RHO5
NOVN
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare RHO5 to other stocks
Unlock Full Access to Alpha Spread
Create Free Account